Last reviewed · How we verify
Povidone-Iodine 0.5%
At a glance
| Generic name | Povidone-Iodine 0.5% |
|---|---|
| Sponsor | Stanford University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Eye pain
- Ocular hypertension
- Vitreous or subconjunctival hemorrhage
- Photopsia
- Uveitis
- Musculoskeletal pain
- Surgery to control IOP
- Dry eye
- Eyelid edema
- Vitreous floaters
- Headache
- Post injection IOP increase >=30 mmHg
Key clinical trials
- Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting (NA)
- Povidone-Iodine Nasal Irrigation After Surgery for Chronic Rhinosinusitis (NA)
- Optimizing the Timing for Facial Surgical Dressing Removal (NA)
- Efficacy of Transversus Abdominis Plane Block in Alleviating Acute Appendicitis (NA)
- Management of Acute Appendicitis Pain in the Emergency Department
- Suprascapular Nerve PRF for Central Sensitization and Neuropathic Pain
- Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (NA)
- Pain Control With Caudal Epidural vs. Combined Caudal Epidural and Lumbar Sympathetic Block . (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Povidone-Iodine 0.5% CI brief — competitive landscape report
- Povidone-Iodine 0.5% updates RSS · CI watch RSS
- Stanford University portfolio CI